Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2023) |
Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 176 | Chinese Journal of Cancer Biotherapy | journal | 0.106 Q4 | 5 | 0 | 332 | 0 | 27 | 332 | 0.10 | 0.00 |  |
| 175 | Clinical and Translational Medicine | journal | 2.424 Q1 | 18 | 0 | 96 | 0 | 546 | 47 | 5.69 | 0.00 |  |
| 174 | Drug Discovery Today: Disease Models | journal | 0.665 Q3 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 |  |
| 173 | Drug Discovery Today: Technologies | journal | 1.241 Q1 | 62 | 0 | 53 | 0 | 295 | 48 | 3.50 | 0.00 | |
| 172 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.104 Q4 | 14 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | |
| 171 | Journal of Stem Cells | journal | 0.101 Q4 | 21 | 0 | 32 | 0 | 0 | 31 | 0.00 | 0.00 | |
| 170 | Frontiers in Anti-infective Drug Discovery | book series | 0.209 Q4 | 3 | 1 | 7 | 124 | 3 | 1 | 0.17 | 124.00 |  |
| 169 | Pteridines | journal | 0.175 Q4 | 19 | 2 | 43 | 83 | 22 | 42 | 0.54 | 41.50 |  |
| 168 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q4 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | |
| 167 | Molecular and Cellular Oncology | journal | 0.471 Q3 | 37 | 4 | 244 | 155 | 237 | 156 | 0.88 | 38.75 | |
| 166 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q3 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | |
| 165 | Biomarker Insights | journal | 0.974 Q2 | 40 | 9 | 67 | 468 | 246 | 59 | 3.34 | 52.00 |  |
| 164 | Molecular Imaging | journal | 0.514 Q3 | 66 | 9 | 60 | 606 | 128 | 60 | 1.97 | 67.33 | |
| 163 | Open Medicinal Chemistry Journal | journal | 0.289 Q4 | 23 | 9 | 22 | 476 | 47 | 19 | 2.80 | 52.89 |  |
| 162 | MCB Molecular and Cellular Biomechanics | journal | 0.315 Q4 | 31 | 10 | 59 | 382 | 76 | 59 | 1.60 | 38.20 | |
| 161 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.168 Q4 | 16 | 12 | 118 | 408 | 61 | 118 | 0.59 | 34.00 | |
| 160 | Cell Stress | journal | 1.852 Q1 | 27 | 12 | 67 | 632 | 350 | 67 | 3.53 | 52.67 |  |
| 159 | Current Pharmacogenomics and Personalized Medicine | journal | 0.127 Q4 | 20 | 12 | 49 | 613 | 9 | 42 | 0.08 | 51.08 | |
| 158 | Eurobiotech Journal | journal | 0.236 Q4 | 10 | 13 | 64 | 573 | 93 | 63 | 1.30 | 44.08 |  |
| 157 | VacciMonitor | journal | 0.133 Q4 | 5 | 14 | 59 | 264 | 15 | 51 | 0.15 | 18.86 |  |
| 156 | OBM Genetics | journal | 0.160 Q4 | 4 | 16 | 68 | 973 | 21 | 63 | 0.38 | 60.81 | |
| 155 | Turkish Computational and Theoretical Chemistry | journal | 0.191 Q4 | 8 | 17 | 30 | 667 | 43 | 30 | 0.89 | 39.24 |  |
| 154 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.283 Q4 | 39 | 22 | 60 | 1112 | 86 | 57 | 1.45 | 50.55 | |
| 153 | European Journal of Medicinal Chemistry Reports | journal | 0.588 Q3 | 11 | 22 | 86 | 1972 | 367 | 86 | 4.27 | 89.64 |  |
| 152 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 25 | 71 | 1315 | 56 | 64 | 0.85 | 52.60 | |
| 151 | Pharmacogenetics and Genomics | journal | 0.563 Q3 | 152 | 25 | 97 | 907 | 208 | 95 | 1.94 | 36.28 | |
| 150 | European Journal of Hybrid Imaging | journal | 0.479 Q3 | 14 | 28 | 87 | 773 | 183 | 87 | 1.73 | 27.61 | |
| 149 | Pharmacogenomics Journal | journal | 0.659 Q3 | 95 | 28 | 194 | 1215 | 524 | 193 | 2.58 | 43.39 | |
| 148 | Extremophiles | journal | 0.726 Q3 | 95 | 29 | 151 | 1759 | 465 | 151 | 2.51 | 60.66 |  |
| 147 | International Journal of Molecular and Cellular Medicine | journal | 0.573 Q3 | 22 | 29 | 58 | 1295 | 159 | 58 | 2.05 | 44.66 |  |
| 146 | Current Cancer Therapy Reviews | journal | 0.172 Q4 | 17 | 30 | 100 | 2663 | 61 | 93 | 0.44 | 88.77 | |
| 145 | Expert Reviews in Molecular Medicine | journal | 1.357 Q1 | 93 | 30 | 72 | 4351 | 398 | 72 | 4.72 | 145.03 | |
| 144 | Acta Naturae | journal | 0.546 Q3 | 36 | 31 | 139 | 1340 | 290 | 139 | 1.69 | 43.23 |  |
| 143 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.258 Q4 | 45 | 31 | 108 | 1193 | 98 | 103 | 0.85 | 38.48 | |
| 142 | Assay and Drug Development Technologies | journal | 0.317 Q4 | 65 | 32 | 126 | 1530 | 234 | 118 | 1.61 | 47.81 | |
| 141 | Blood Cells, Molecules, and Diseases | journal | 0.584 Q3 | 98 | 32 | 192 | 1217 | 313 | 154 | 1.65 | 38.03 | |
| 140 | Cellular Therapy and Transplantation | journal | 0.170 Q4 | 8 | 32 | 90 | 970 | 26 | 88 | 0.25 | 30.31 | |
| 139 | Clinical and Experimental Morphology | journal | 0.126 Q4 | 4 | 33 | 91 | 990 | 30 | 91 | 0.38 | 30.00 | |
| 138 | Current Gene Therapy | journal | 0.674 Q3 | 80 | 33 | 114 | 3190 | 359 | 106 | 3.41 | 96.67 | |
| 137 | Nucleic Acid Therapeutics | journal | 1.252 Q1 | 77 | 33 | 125 | 1583 | 502 | 122 | 3.95 | 47.97 | |
| 136 | Pharmacological Reviews | journal | 6.050 Q1 | 254 | 35 | 102 | 13259 | 2111 | 100 | 19.42 | 378.83 | |
| 135 | Current Computer-Aided Drug Design | journal | 0.283 Q4 | 32 | 36 | 197 | 1766 | 365 | 191 | 1.76 | 49.06 | |
| 134 | Molecular Cytogenetics | journal | 0.403 Q4 | 38 | 36 | 160 | 1356 | 225 | 159 | 1.43 | 37.67 | |
| 133 | Proceedings of the Shevchenko Scientific Society. Medical Sciences | journal | 0.123 Q4 | 4 | 37 | 111 | 1159 | 30 | 106 | 0.28 | 31.32 |  |
| 132 | Cold Spring Harbor molecular case studies | journal | 0.801 Q2 | 25 | 38 | 190 | 1110 | 337 | 189 | 1.80 | 29.21 | |
| 131 | Advances in Biological Regulation | journal | 1.114 Q2 | 69 | 39 | 111 | 2651 | 395 | 105 | 2.77 | 67.97 | |
| 130 | Nanomedicine Research Journal | journal | 0.304 Q4 | 20 | 39 | 120 | 1819 | 243 | 120 | 1.85 | 46.64 | |
| 129 | FASEB BioAdvances | journal | 0.764 Q2 | 18 | 40 | 210 | 1940 | 560 | 202 | 2.52 | 48.50 | |
| 128 | Analytical Cellular Pathology | journal | 0.711 Q3 | 35 | 41 | 179 | 1741 | 523 | 177 | 2.61 | 42.46 |  |
| 127 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data